Western Oncolytics Ltd. develops novel therapies for cancer. The Company commercializes cutting-edge treatments that show promise in early laboratory research and demonstrates their value to patients in clinical trials. The Company expects its lead technology, a novel immuno-oncolytic therapy, will extend the lives of, or outright cure, patients across a wide range of cancer types while avoiding the severe side effects common with current cancer therapies. Western Oncolytics aims to use the most sophisticated science to give life and hope to cancer patients.
